New medicine for acute lung failure in adults
Part of Lungs & breathing clinical trials.
This trial tests a new medicine (LEAF-4L6715) for people with acute respiratory distress syndrome (ARDS), a serious lung condition. The aim is to see if this medicine helps improve breathing and recovery in people on a breathing machine. The trial is for adults who have had ARDS for at least 24 hours and are already on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have acute respiratory distress syndrome (ARDS), a severe lung condition, with low oxygen levels despite being on a breathing machine for at least 24 hours.
- You must have a breathing tube in your windpipe or a tracheostomy.
- You must not have severe chronic lung disease that requires home oxygen or a breathing machine.
- You must not be on a heart-lung bypass machine (ECMO) or have been on a breathing machine for more than 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
This trial tests an experimental drug called R-3750 for people with a severe lung condition called ARDS that has not improved after at least a week. The drug is given through a tube into the stomach, and the goal is to see if it can help the lungs recover.
This study looks at starting a specific type of breathing machine setting early in people with ARDS (a serious lung problem) to see if it improves outcomes. You might be able to take part if you are within 48 hours of needing a breathing tube and meet the lung oxygen criteria.
This trial tests a new treatment using stem cells from umbilical cords, given through an IV, for people with severe ARDS. The goal is to see if it's safe and helps improve breathing.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.